½ÃÀ庸°í¼­
»óǰÄÚµå
1622861

¹ÝÈç Ä¡·á ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2025-2032³â)

Scar Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Persistence Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 170 Pages | ¹è¼Û¾È³» : 2-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÁÖ¿ä ÀλçÀÌÆ®

  • ¹ÝÈç Ä¡·á ½ÃÀå ±Ô¸ð : 206¾ï ´Þ·¯(2025³â)
  • ¿¹ÃøµÇ´Â ½ÃÀå ±Ý¾× : 442¾ï ´Þ·¯(2032³â)
  • ¼¼°è ½ÃÀåÀÇ ¼ºÀå·ü : 11.5%(2025-2032³â CAGR)

¹ÝÈç Ä¡·á ½ÃÀå - ¸®Æ÷Æ® ¹üÀ§

¹ÝÈç Ä¡·á´Â ºÎ»ó, ¼ö¼ú, È­»ó, ¿©µå¸§ µî ´Ù¾çÇÑ ¿äÀÎÀ¸·Î ÀÎÇØ »ý±ä ÈäÅÍÀÇ ¸ð¾ç°ú Áú°¨À» °³¼±ÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÈäÅÍ Ä¡·á ½ÃÀå¿¡´Â ÈäÅ͸¦ ´«¿¡ ¶çÁö ¾Ê°Ô Çϰí ÇǺΠġÀ¯¸¦ ÃËÁøÇÏ´Â ¿Ü¿ë Á©, ½Ç¸®ÄÜ ½ÃÆ®, ·¹ÀÌÀú Ä¡·á µîÀÇ Á¦Ç°ÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ ½ÃÀåÀº ÀÇ·á ½Ã¼³, ÇǺΰú Ŭ¸®´Ð, ȨÄɾî ȯ°æ µî ¿©·¯ ºÎ¹®¿¡ ¼­ºñ½º¸¦ Á¦°øÇÕ´Ï´Ù. È¿°úÀûÀÎ ÈäÅÍ Ä¡·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ±â¼ú ¹ßÀü, Àü ¼¼°è ¼ö¼ú ¹× ¿Ü»ó ȯÀÚ Áõ°¡ µîÀÌ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ

¼¼°è ÈäÅÍ Ä¡·á ½ÃÀåÀº ÈäÅÍ·Î À̾îÁö´Â ¼ö¼ú ¹× »ç°í Áõ°¡, ÷´Ü ÈäÅÍ Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ¹Ì¿ë ¼ºÇü¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µî ¿©·¯ °¡Áö ÁÖ¿ä ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¹Ì¿ë ¹× ÇǺΰú Ä¡·áÀÇ È®´ë, ·¹ÀÌÀú Ä¡·á ¹× ¸¶ÀÌÅ©·Î´Ïµé µîÀÇ ±â¼ú ¹ßÀüÀº ÈäÅÍ Ä¡·áÀÇ È¿°ú¸¦ Å©°Ô Çâ»ó½ÃÄÑ ½ÃÀå È®´ë¸¦ ÃËÁøÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ °æ¹ÌÇÑ ÈäÅÍ¿¡ ´ëÇÑ ½ÃÆÇ ÁßÀÎ ÈäÅÍ Ä¡·á Á¦Ç°ÀÇ Ã¤Åà Ȯ´ë¿Í ºñħ½ÀÀû Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ °ü½É Áõ°¡µµ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ

À¯¸ÁÇÑ ¼ºÀå¿¡µµ ºÒ±¸Çϰí ÈäÅÍ Ä¡·á ½ÃÀåÀº °í±Þ ÈäÅÍ Ä¡·áÀÇ ³ôÀº ºñ¿ë°ú Àú·ÅÇÑ ´ëü Ä¡·á¹ýÀÇ °¡¿ë¼º¿¡ ´ëÇÑ ¹®Á¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÈäÅÍ Ä¡·áÀÇ È¿°ú´Â °³ÀÎÂ÷°¡ ÀÖ°í, ÀϺΠÈäÅÍ´Â Ä¡·á¿¡ ¹ÝÀÀÇÏÁö ¾Ê´Â °æ¿ìµµ ÀÖÀ¸¸ç, ½ÃÀåÀÇ ÀáÀç·ÂÀ» Á¦ÇÑÇϰí ÀÖ½À´Ï´Ù. Á¦Ç° ½ÂÀο¡ ´ëÇÑ ±ÔÁ¦ À庮°ú ·¹ÀÌÀú Ä¡·á¿Í °°Àº ÀϺΠġ·á¹ýÀÇ ¾ÈÀü¼º¿¡ ´ëÇÑ ¿ì·Á´Â ƯÈ÷ ÀÇ·á ±ÔÁ¦°¡ ¾ö°ÝÇÑ Áö¿ª¿¡¼­ ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ±âȸ

ÈäÅÍ Ä¡·á ½ÃÀåÀº Ä¡·á¹ý Çõ½Å°ú Àα¸ Åë°èÇÐÀû Ãß¼¼·Î ÀÎÇØ Å« ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ÈäÅÍ ¸ð´ÏÅ͸µ¿¡ »ç¿ëµÇ´Â ¸ð¹ÙÀÏ ¾ÖÇø®ÄÉÀÌ¼Ç ¹× ¿ø°ÝÀÇ·á Ç÷§Æû°ú °°Àº µðÁöÅÐ ±â¼úÀÇ ÅëÇÕÀº ȯÀÚÀÇ Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» ³ôÀ̰í Ä¡·á ¼øÀÀµµ¸¦ Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ Àç»ýÀÇ·á¿Í Áٱ⼼Æ÷ Ä¡·áÀÇ ¹ßÀü°ú ÇÔ²² °³ÀÎ ¸ÂÃãÇü ÈäÅÍ Ä¡·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÈäÅÍ Ä¡·á¿¡ ´ëÇÑ Àνİú ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ´Â ½ÅÈï ½ÃÀåÀ¸·ÎÀÇ ÁøÃâÀº ½ÃÀå ±â¾÷¿¡°Ô »õ·Î¿î ¼ºÀå °æ·Î¸¦ Á¦°øÇÕ´Ï´Ù.

¼¼°èÀÇ ¹ÝÈç Ä¡·á ½ÃÀå¿¡ ´ëÇØ Á¶»çºÐ¼®ÇßÀ¸¸ç, ¼ºÀå ÃËÁø¿äÀÎ, µ¿Çâ, ±âȸ, °úÁ¦ µî ½ÃÀå ¿ªÇÐÀÇ »ó¼¼ ºÐ¼®À» Á¦°øÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå ½ÃÀå °³¿ä

  • ½ÃÀåÀÇ ¹üÀ§¿Í Á¤ÀÇ
  • ½ÃÀå ¿ªÇÐ
    • ÃËÁø¿äÀÎ
    • ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
    • ÁÖ¿ä µ¿Çâ
  • °Å½Ã°æÁ¦ ¿äÀÎ
    • ¼¼°èÀÇ GDP ¼ºÀå Àü¸Á
    • ¼¼°èÀÇ ÀÇ·áºñ Àü¸Á
  • COVID-19ÀÇ ¿µÇ⠺м®
  • ¿¹Ãø ¿äÀÎ - °ü·Ã¼º°ú ¿µÇâ

Á¦3Àå ºÎ°¡°¡Ä¡ ÀλçÀÌÆ®

  • Á¦Ç° äÅà ºÐ¼®
  • Áúº´ ¿ªÇÐ
  • ±ÔÁ¦ »óȲ
  • ¹ë·ùüÀÎ ºÐ¼®
  • ÁÖ¿ä °Å·¡¿Í ÇÕº´
  • PESTLE ºÐ¼®
  • Porter's Five Forces ºÐ¼®

Á¦4Àå ¼¼°èÀÇ ¹ÝÈç Ä¡·á ½ÃÀå Àü¸Á : °ú°Å(2019-2023³â)¿Í ¿¹Ãø(2025-2032³â)

  • ¼¼°èÀÇ ¹ÝÈç Ä¡·á ½ÃÀå Àü¸Á : Á¦Ç°
    • ½ÃÀå ±Ô¸ð ºÐ¼® : Á¦Ç°º°(2019-2023³â)
    • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : Á¦Ç°º°(2025-2032³â)
    • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : Á¦Ç°
  • ¼¼°èÀÇ ¹ÝÈç Ä¡·á ½ÃÀå Àü¸Á : ¿ëµµ
    • ½ÃÀå ±Ô¸ð ºÐ¼® : ¿ëµµº°(2019-2023³â)
    • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : ¿ëµµº°(2025-2032³â)
    • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ¿ëµµ
  • ¼¼°èÀÇ ¹ÝÈç Ä¡·á ½ÃÀå Àü¸Á : ÃÖÁ¾ ¿ëµµ
    • ½ÃÀå ±Ô¸ð ºÐ¼® : ÃÖÁ¾ ¿ëµµº°(2019-2023³â)
    • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : ÃÖÁ¾ ¿ëµµº°(2025-2032³â)
    • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ÃÖÁ¾ ¿ëµµ

Á¦5Àå ¼¼°èÀÇ ¹ÝÈç Ä¡·á ½ÃÀå Àü¸Á : Áö¿ª

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • ½ÃÀå ±Ô¸ð ºÐ¼® : Áö¿ªº°(2019-2023³â)
  • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : Áö¿ªº°(2025-2032³â)
    • ºÏ¹Ì
    • À¯·´
    • µ¿¾Æ½Ã¾Æ
    • ³²¾Æ½Ã¾Æ¡¤¿À¼¼¾Æ´Ï¾Æ
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : Áö¿ª

Á¦6Àå ºÏ¹ÌÀÇ ¹ÝÈç Ä¡·á ½ÃÀå Àü¸Á : °ú°Å(2019-2023³â)¿Í ¿¹Ãø(2025-2032³â)

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • °¡°Ý ºÐ¼®
  • ½ÃÀå ±Ô¸ð ºÐ¼® : ½ÃÀ庰(2019-2023³â)
    • ±¹°¡º°
    • Á¦Ç°º°
    • ¿ëµµº°
    • ÃÖÁ¾ ¿ëµµº°
  • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : ±¹°¡º°(2025-2032³â)
    • ¹Ì±¹
    • ij³ª´Ù
  • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : Á¦Ç°º°(2025-2032³â)
    • ¿Ü¿ë Á¦Ç°
    • ·¹ÀÌÀú Á¦Ç°
    • Ç¥¸é Ä¡·á Á¦Ç°
    • ÁÖ»ç Á¦Ç°
  • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : ¿ëµµº°(2025-2032³â)
    • À§Ã༺¹ÝÈç
    • ºñÈļº¹ÝÈç, ÄÌ·ÎÀ̵å
    • ±¸Ãà
    • ½ºÆ®·¹Ä¡ ¸¶Å©
  • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : ÃÖÁ¾ ¿ëµµº°(2025-2032³â)
    • º´¿ø
    • Áø·á¼Ò
    • ¾à±¹¡¤µå·¯±×½ºÅä¾î
    • E-Commerce
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦7Àå À¯·´ÀÇ ¹ÝÈç Ä¡·á ½ÃÀå Àü¸Á : °ú°Å(2019-2023³â)¿Í ¿¹Ãø(2025-2032³â)

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • °¡°Ý ºÐ¼®
  • ½ÃÀå ±Ô¸ð ºÐ¼® : ½ÃÀ庰(2019-2023³â)
    • ±¹°¡º°
    • Á¦Ç°º°
    • ¿ëµµº°
    • ÃÖÁ¾ ¿ëµµº°
  • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : ±¹°¡º°(2025-2032³â)
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ·¯½Ã¾Æ
    • ÅÍŰ
    • ±âŸ À¯·´
  • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : Á¦Ç°º°(2025-2032³â)
    • ¿Ü¿ë Á¦Ç°
    • ·¹ÀÌÀú Á¦Ç°
    • Ç¥¸é Ä¡·á Á¦Ç°
    • ÁÖ»ç Á¦Ç°
  • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : ¿ëµµº°(2025-2032³â)
    • À§Ã༺¹ÝÈç
    • ºñÈļº¹ÝÈç, ÄÌ·ÎÀ̵å
    • ±¸Ãà
    • ½ºÆ®·¹Ä¡ ¸¶Å©
  • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : ÃÖÁ¾ ¿ëµµº°(2025-2032³â)
    • º´¿ø
    • Áø·á¼Ò
    • ¾à±¹¡¤µå·¯±×½ºÅä¾î
    • E-Commerce
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦8Àå µ¿¾Æ½Ã¾ÆÀÇ ¹ÝÈç Ä¡·á ½ÃÀå Àü¸Á : °ú°Å(2019-2023³â)¿Í ¿¹Ãø(2025-2032³â)

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • °¡°Ý ºÐ¼®
  • ½ÃÀå ±Ô¸ð ºÐ¼® : ½ÃÀ庰(2019-2023³â)
    • ±¹°¡º°
    • Á¦Ç°º°
    • ¿ëµµº°
    • ÃÖÁ¾ ¿ëµµº°
  • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : ±¹°¡º°(2025-2032³â)
    • Áß±¹
    • ÀϺ»
    • Çѱ¹
  • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : Á¦Ç°º°(2025-2032³â)
    • ¿Ü¿ë Á¦Ç°
    • ·¹ÀÌÀú Á¦Ç°
    • Ç¥¸é Ä¡·á Á¦Ç°
    • ÁÖ»ç Á¦Ç°
  • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : ¿ëµµº°(2025-2032³â)
    • À§Ã༺¹ÝÈç
    • ºñÈļº¹ÝÈç, ÄÌ·ÎÀ̵å
    • ±¸Ãà
    • ½ºÆ®·¹Ä¡ ¸¶Å©
  • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : ÃÖÁ¾ ¿ëµµº°(2025-2032³â)
    • º´¿ø
    • Áø·á¼Ò
    • ¾à±¹¡¤µå·¯±×½ºÅä¾î
    • E-Commerce
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦9Àå ³²¾Æ½Ã¾Æ¡¤¿À¼¼¾Æ´Ï¾ÆÀÇ ¹ÝÈç Ä¡·á ½ÃÀå Àü¸Á : °ú°Å(2019-2023³â)¿Í ¿¹Ãø(2025-2032³â)

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • °¡°Ý ºÐ¼®
  • ½ÃÀå ±Ô¸ð ºÐ¼® : ½ÃÀ庰(2019-2023³â)
    • ±¹°¡º°
    • Á¦Ç°º°
    • ¿ëµµº°
    • ÃÖÁ¾ ¿ëµµº°
  • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : ±¹°¡º°(2025-2032³â)
    • Àεµ
    • µ¿³²¾Æ½Ã¾Æ
    • È£ÁÖ
    • ±âŸ ³²¾Æ½Ã¾Æ¡¤¿À¼¼¾Æ´Ï¾Æ
  • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : Á¦Ç°º°(2025-2032³â)
    • ¿Ü¿ë Á¦Ç°
    • ·¹ÀÌÀú Á¦Ç°
    • Ç¥¸é Ä¡·á Á¦Ç°
    • ÁÖ»ç Á¦Ç°
  • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : ¿ëµµº°(2025-2032³â)
    • À§Ã༺¹ÝÈç
    • ºñÈļº¹ÝÈç, ÄÌ·ÎÀ̵å
    • ±¸Ãà
    • ½ºÆ®·¹Ä¡ ¸¶Å©
  • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : ÃÖÁ¾ ¿ëµµº°(2025-2032³â)
    • º´¿ø
    • Áø·á¼Ò
    • ¾à±¹¡¤µå·¯±×½ºÅä¾î
    • E-Commerce
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦10Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ ¹ÝÈç Ä¡·á ½ÃÀå Àü¸Á : °ú°Å(2019-2023³â)¿Í ¿¹Ãø(2025-2032³â)

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • °¡°Ý ºÐ¼®
  • ½ÃÀå ±Ô¸ð ºÐ¼® : ½ÃÀ庰(2019-2023³â)
    • ±¹°¡º°
    • Á¦Ç°º°
    • ¿ëµµº°
    • ÃÖÁ¾ ¿ëµµº°
  • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : ±¹°¡º°(2025-2032³â)
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : Á¦Ç°º°(2025-2032³â)
    • ¿Ü¿ë Á¦Ç°
    • ·¹ÀÌÀú Á¦Ç°
    • Ç¥¸é Ä¡·á Á¦Ç°
    • ÁÖ»ç Á¦Ç°
  • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : ¿ëµµº°(2025-2032³â)
    • À§Ã༺¹ÝÈç
    • ºñÈļº¹ÝÈç, ÄÌ·ÎÀ̵å
    • ±¸Ãà
    • ½ºÆ®·¹Ä¡ ¸¶Å©
  • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : ÃÖÁ¾ ¿ëµµº°(2025-2032³â)
    • º´¿ø
    • Áø·á¼Ò
    • ¾à±¹¡¤µå·¯±×½ºÅä¾î
    • E-Commerce
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦11Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¹ÝÈç Ä¡·á ½ÃÀå Àü¸Á : °ú°Å(2019-2023³â)¿Í ¿¹Ãø(2025-2032³â)

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • °¡°Ý ºÐ¼®
  • ½ÃÀå ±Ô¸ð ºÐ¼® : ½ÃÀ庰(2019-2023³â)
    • ±¹°¡º°
    • Á¦Ç°º°
    • ¿ëµµº°
    • ÃÖÁ¾ ¿ëµµº°
  • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : ±¹°¡º°(2025-2032³â)
    • GCC ±¹°¡
    • ÀÌÁýÆ®
    • ³²¾ÆÇÁ¸®Ä«
    • ºÏ¾ÆÇÁ¸®Ä«
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : Á¦Ç°º°(2025-2032³â)
    • ¿Ü¿ë Á¦Ç°
    • ·¹ÀÌÀú Á¦Ç°
    • Ç¥¸é Ä¡·á Á¦Ç°
    • ÁÖ»ç Á¦Ç°
  • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : ¿ëµµº°(2025-2032³â)
    • À§Ã༺¹ÝÈç
    • ºñÈļº¹ÝÈç, ÄÌ·ÎÀ̵å
    • ±¸Ãà
    • ½ºÆ®·¹Ä¡ ¸¶Å©
  • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : ÃÖÁ¾ ¿ëµµº°(2025-2032³â)
    • º´¿ø
    • Áø·á¼Ò
    • ¾à±¹¡¤µå·¯±×½ºÅä¾î
    • E-Commerce
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2024³â)
  • ½ÃÀå ±¸Á¶
    • °æÀï °­µµ ¸Ê : ½ÃÀ庰
    • °æÀï ´ë½Ãº¸µå
  • ±â¾÷ °³¿ä(»ó¼¼ - °³¿ä, À繫, Àü·«, ÃÖ±Ù µ¿Çâ)
    • Smith and Nephew plc.
    • HRA Pharma
    • Sonoma Pharmaceuticals, Inc.
    • CCA Industries Inc.
    • Cynosure, Inc.
    • Avita Medical Limited
    • Molnlycke Health Care AB
    • Pacific World Corporation
    • Shanghai Fosun Pharmaceuticals Ltd.
    • Beijing Toplaser Technology Company Limited
    • Bausch Health Companies Inc.
    • ±âŸ

Á¦13Àå ºÎ·Ï

KSA 25.01.16

Persistence Market Research has recently released a comprehensive report on the worldwide market for scar treatment. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global scar treatment market from 2025 to 2032.

Key Insights:

  • Scar Treatment Market Size (2025E): US$ 20.6 Bn
  • Projected Market Value (2032F): US$ 44.2 Bn
  • Global Market Growth Rate (CAGR 2025 to 2032): 11.5%

Scar Treatment Market - Report Scope:

Scar treatment plays a crucial role in improving the appearance and texture of scars caused by various factors, including injuries, surgeries, burns, and acne. The scar treatment market includes products such as topical gels, silicone sheets, and laser therapies that help to reduce scar visibility and promote skin healing. The market serves multiple sectors, including healthcare facilities, dermatology clinics, and homecare settings. The growth is driven by rising demand for effective scar treatment solutions, advancements in technology, and an increasing number of surgical procedures and trauma cases globally.

Market Growth Drivers:

The global scar treatment market is driven by several key factors, including an increasing number of surgical procedures and accidents leading to scarring, growing awareness about advanced scar treatment options, and the rising demand for cosmetic procedures. The expansion of medical aesthetics and dermatology treatments, along with technological advancements such as laser therapies and micro-needling, significantly enhance the effectiveness of scar treatments, driving market expansion. Furthermore, the growing adoption of over-the-counter scar treatment products for minor scars and the increasing focus on non-invasive treatment options also contribute to market growth.

Market Restraints:

Despite promising growth, the scar treatment market faces challenges related to the high costs of advanced scar treatment therapies and the availability of inexpensive alternative treatments. Additionally, the effectiveness of scar treatments varies across different individuals, and certain scars may not respond well to treatment, limiting market potential. Regulatory hurdles for product approvals and concerns regarding the safety of some treatment methods, such as laser therapy, could impact market growth, especially in regions with stringent healthcare regulations.

Market Opportunities:

The scar treatment market presents significant opportunities driven by innovations in treatment methods and demographic trends. The integration of digital technologies such as mobile applications for scar monitoring and telemedicine platforms enhances patient access to treatment options and improves adherence. Moreover, there is a growing trend of personalized scar treatment solutions, with advancements in regenerative medicine and stem cell therapies. Expansion into emerging markets, where the awareness and demand for scar treatments are increasing, offers new growth avenues for market players.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the scar treatment market globally?
  • Which treatment types and applications are seeing increased adoption for scar management across different healthcare settings?
  • How are technological advancements reshaping the competitive landscape of the scar treatment market?
  • Who are the key players contributing to the scar treatment market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global scar treatment market?

Competitive Intelligence and Business Strategy:

Leading players in the global scar treatment market, including Mederma (Merz Pharmaceuticals), Smith & Nephew, and Hologic, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced scar treatment solutions, including silicone-based products, laser devices, and regenerative therapies. Collaborations with dermatology clinics, medical device distributors, and healthcare providers help market access and foster technology adoption. Furthermore, clinical research, patient education, and awareness campaigns promote product effectiveness and improve patient outcomes in the scar treatment sector.

Key Companies Profiled:

  • Mederma (Merz Pharmaceuticals)
  • Smith & Nephew
  • Hologic
  • Kelo-Cote (Fairhaven Health)
  • 3M
  • Allergan
  • Stratpharma AG
  • Avita Medical
  • Enaltus LLC
  • Derma E

Market Segmentation

By Product

  • Topical products
  • Laser products
  • Surface treatment products
  • Injectable products

By Application

  • Atrophic scars
  • Hypertrophic Scars and Keloids
  • Contractures
  • Stretch Marks

By End Use

  • Hospitals
  • Clinics
  • Pharmacies & Drug stores
  • E-commerce

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Scar Treatment Market Snapshot, 2025 - 2032
  • 1.2. Market Opportunity Assessment, 2025 - 2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global GDP Growth Outlook
    • 2.3.2. Global Healthcare Spending Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Disease Epidemiology
  • 3.3. Regulatory Landscape
  • 3.4. Value Chain Analysis
  • 3.5. Key Deals and Mergers
  • 3.6. PESTLE Analysis
  • 3.7. Porter's Five Force Analysis

4. Global Scar Treatment Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 4.1. Global Scar Treatment Market Outlook: Product
    • 4.1.1. Introduction / Key Findings
    • 4.1.2. Historical Market Size (US$ Bn) Analysis, By Product, 2019 - 2023
    • 4.1.3. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025 - 2032
      • 4.1.3.1. Topical products
        • 4.1.3.1.1. Gels
        • 4.1.3.1.2. Creams
        • 4.1.3.1.3. Oils
        • 4.1.3.1.4. Sheets
      • 4.1.3.2. Laser products
        • 4.1.3.2.1. CO2 Laser
        • 4.1.3.2.2. Excimer Laser
        • 4.1.3.2.3. Pulsed dyed Laser
      • 4.1.3.3. Surface treatment products
      • 4.1.3.4. Injectable products
    • 4.1.4. Market Attractiveness Analysis: Product
  • 4.2. Global Scar Treatment Market Outlook: Application
    • 4.2.1. Introduction / Key Findings
    • 4.2.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019 - 2023
    • 4.2.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 - 2032
      • 4.2.3.1. Atrophic scars
        • 4.2.3.1.1. Acne
        • 4.2.3.1.1.1. Ice Pick
        • 4.2.3.1.1.2. Box Scar
        • 4.2.3.1.1.3. Rolling Acne
        • 4.2.3.1.2. Trauma and Surgery
      • 4.2.3.2. Hypertrophic Scars and Keloids
      • 4.2.3.3. Contractures
      • 4.2.3.4. Stretch Marks
    • 4.2.4. Market Attractiveness Analysis: Application
  • 4.3. Global Scar Treatment Market Outlook: End-use
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Bn) Analysis, By End-use, 2019 - 2023
    • 4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025 - 2032
      • 4.3.3.1. Hospitals
      • 4.3.3.2. Clinics
      • 4.3.3.3. Pharmacies & Drug stores
      • 4.3.3.4. E-commerce
    • 4.3.4. Market Attractiveness Analysis: End-use

5. Global Scar Treatment Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019 - 2023
  • 5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2025 - 2032
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Scar Treatment Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 6.1. Key Highlights
  • 6.2. Pricing Analysis
  • 6.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 6.3.1. By Country
    • 6.3.2. By Product
    • 6.3.3. By Application
    • 6.3.4. By End Use
  • 6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
    • 6.4.1. U.S.
    • 6.4.2. Canada
  • 6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025 - 2032
    • 6.5.1. Topical products
      • 6.5.1.1. Gels
      • 6.5.1.2. Creams
      • 6.5.1.3. Oils
      • 6.5.1.4. Sheets
    • 6.5.2. Laser products
      • 6.5.2.1. CO2 Laser
      • 6.5.2.2. Excimer Laser
      • 6.5.2.3. Pulsed dyed Laser
    • 6.5.3. Surface treatment products
    • 6.5.4. Injectable products
  • 6.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 - 2032
    • 6.6.1. Atrophic scars
      • 6.6.1.1. Acne
        • 6.6.1.1.1. Ice Pick
        • 6.6.1.1.2. Box Scar
        • 6.6.1.1.3. Rolling Acne
      • 6.6.1.2. Trauma and Surgery
    • 6.6.2. Hypertrophic Scars and Keloids
    • 6.6.3. Contractures
    • 6.6.4. Stretch Marks
  • 6.7. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2025 - 2032
    • 6.7.1. Hospitals
    • 6.7.2. Clinics
    • 6.7.3. Pharmacies & Drug stores
    • 6.7.4. E-commerce
  • 6.8. Market Attractiveness Analysis

7. Europe Scar Treatment Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 7.3.1. By Country
    • 7.3.2. By Product
    • 7.3.3. By Application
    • 7.3.4. By End Use
  • 7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
    • 7.4.1. Germany
    • 7.4.2. France
    • 7.4.3. U.K.
    • 7.4.4. Italy
    • 7.4.5. Spain
    • 7.4.6. Russia
    • 7.4.7. Turkey
    • 7.4.8. Rest of Europe
  • 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025 - 2032
    • 7.5.1. Topical products
      • 7.5.1.1. Gels
      • 7.5.1.2. Creams
      • 7.5.1.3. Oils
      • 7.5.1.4. Sheets
    • 7.5.2. Laser products
      • 7.5.2.1. CO2 Laser
      • 7.5.2.2. Excimer Laser
      • 7.5.2.3. Pulsed dyed Laser
    • 7.5.3. Surface treatment products
    • 7.5.4. Injectable products
  • 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 - 2032
    • 7.6.1. Atrophic scars
      • 7.6.1.1. Acne
        • 7.6.1.1.1. Ice Pick
        • 7.6.1.1.2. Box Scar
        • 7.6.1.1.3. Rolling Acne
      • 7.6.1.2. Trauma and Surgery
    • 7.6.2. Hypertrophic Scars and Keloids
    • 7.6.3. Contractures
    • 7.6.4. Stretch Marks
  • 7.7. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2025 - 2032
    • 7.7.1. Hospitals
    • 7.7.2. Clinics
    • 7.7.3. Pharmacies & Drug stores
    • 7.7.4. E-commerce
  • 7.8. Market Attractiveness Analysis

8. East Asia Scar Treatment Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 8.3.1. By Country
    • 8.3.2. By Product
    • 8.3.3. By Application
    • 8.3.4. By End Use
  • 8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
    • 8.4.1. China
    • 8.4.2. Japan
    • 8.4.3. South Korea
  • 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025 - 2032
    • 8.5.1. Topical products
      • 8.5.1.1. Gels
      • 8.5.1.2. Creams
      • 8.5.1.3. Oils
      • 8.5.1.4. Sheets
    • 8.5.2. Laser products
      • 8.5.2.1. CO2 Laser
      • 8.5.2.2. Excimer Laser
      • 8.5.2.3. Pulsed dyed Laser
    • 8.5.3. Surface treatment products
    • 8.5.4. Injectable products
  • 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 - 2032
    • 8.6.1. Atrophic scars
      • 8.6.1.1. Acne
        • 8.6.1.1.1. Ice Pick
        • 8.6.1.1.2. Box Scar
        • 8.6.1.1.3. Rolling Acne
      • 8.6.1.2. Trauma and Surgery
    • 8.6.2. Hypertrophic Scars and Keloids
    • 8.6.3. Contractures
    • 8.6.4. Stretch Marks
  • 8.7. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2025 - 2032
    • 8.7.1. Hospitals
    • 8.7.2. Clinics
    • 8.7.3. Pharmacies & Drug stores
    • 8.7.4. E-commerce
  • 8.8. Market Attractiveness Analysis

9. South Asia & Oceania Scar Treatment Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 9.3.1. By Country
    • 9.3.2. By Product
    • 9.3.3. By Application
    • 9.3.4. By End Use
  • 9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
    • 9.4.1. India
    • 9.4.2. Southeast Asia
    • 9.4.3. ANZ
    • 9.4.4. Rest of South Asia & Oceania
  • 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025 - 2032
    • 9.5.1. Topical products
      • 9.5.1.1. Gels
      • 9.5.1.2. Creams
      • 9.5.1.3. Oils
      • 9.5.1.4. Sheets
    • 9.5.2. Laser products
      • 9.5.2.1. CO2 Laser
      • 9.5.2.2. Excimer Laser
      • 9.5.2.3. Pulsed dyed Laser
    • 9.5.3. Surface treatment products
    • 9.5.4. Injectable products
  • 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 - 2032
    • 9.6.1. Atrophic scars
      • 9.6.1.1. Acne
        • 9.6.1.1.1. Ice Pick
        • 9.6.1.1.2. Box Scar
        • 9.6.1.1.3. Rolling Acne
      • 9.6.1.2. Trauma and Surgery
    • 9.6.2. Hypertrophic Scars and Keloids
    • 9.6.3. Contractures
    • 9.6.4. Stretch Marks
  • 9.7. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2025 - 2032
    • 9.7.1. Hospitals
    • 9.7.2. Clinics
    • 9.7.3. Pharmacies & Drug stores
    • 9.7.4. E-commerce
  • 9.8. Market Attractiveness Analysis

10. Latin America Scar Treatment Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 10.3.1. By Country
    • 10.3.2. By Product
    • 10.3.3. By Application
    • 10.3.4. By End Use
  • 10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
    • 10.4.1. Brazil
    • 10.4.2. Mexico
    • 10.4.3. Rest of Latin America
  • 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025 - 2032
    • 10.5.1. Topical products
      • 10.5.1.1. Gels
      • 10.5.1.2. Creams
      • 10.5.1.3. Oils
      • 10.5.1.4. Sheets
    • 10.5.2. Laser products
      • 10.5.2.1. CO2 Laser
      • 10.5.2.2. Excimer Laser
      • 10.5.2.3. Pulsed dyed Laser
    • 10.5.3. Surface treatment products
    • 10.5.4. Injectable products
  • 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 - 2032
    • 10.6.1. Atrophic scars
      • 10.6.1.1. Acne
        • 10.6.1.1.1. Ice Pick
        • 10.6.1.1.2. Box Scar
        • 10.6.1.1.3. Rolling Acne
      • 10.6.1.2. Trauma and Surgery
    • 10.6.2. Hypertrophic Scars and Keloids
    • 10.6.3. Contractures
    • 10.6.4. Stretch Marks
  • 10.7. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2025 - 2032
    • 10.7.1. Hospitals
    • 10.7.2. Clinics
    • 10.7.3. Pharmacies & Drug stores
    • 10.7.4. E-commerce
  • 10.8. Market Attractiveness Analysis

11. Middle East & Africa Scar Treatment Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 11.1. Key Highlights
  • 11.2. Pricing Analysis
  • 11.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 11.3.1. By Country
    • 11.3.2. By Product
    • 11.3.3. By Application
    • 11.3.4. By End Use
  • 11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
    • 11.4.1. GCC Countries
    • 11.4.2. Egypt
    • 11.4.3. South Africa
    • 11.4.4. Northern Africa
    • 11.4.5. Rest of Middle East & Africa
  • 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025 - 2032
    • 11.5.1. Topical products
      • 11.5.1.1. Gels
      • 11.5.1.2. Creams
      • 11.5.1.3. Oils
      • 11.5.1.4. Sheets
    • 11.5.2. Laser products
      • 11.5.2.1. CO2 Laser
      • 11.5.2.2. Excimer Laser
      • 11.5.2.3. Pulsed dyed Laser
    • 11.5.3. Surface treatment products
    • 11.5.4. Injectable products
  • 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 - 2032
    • 11.6.1. Atrophic scars
      • 11.6.1.1. Acne
        • 11.6.1.1.1. Ice Pick
        • 11.6.1.1.2. Box Scar
        • 11.6.1.1.3. Rolling Acne
      • 11.6.1.2. Trauma and Surgery
    • 11.6.2. Hypertrophic Scars and Keloids
    • 11.6.3. Contractures
    • 11.6.4. Stretch Marks
  • 11.7. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2025 - 2032
    • 11.7.1. Hospitals
    • 11.7.2. Clinics
    • 11.7.3. Pharmacies & Drug stores
    • 11.7.4. E-commerce
  • 11.8. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2024
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Smith and Nephew plc.
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Products
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. HRA Pharma
    • 12.3.3. Sonoma Pharmaceuticals, Inc.
    • 12.3.4. CCA Industries Inc.
    • 12.3.5. Cynosure, Inc.
    • 12.3.6. Avita Medical Limited
    • 12.3.7. Molnlycke Health Care AB
    • 12.3.8. Pacific World Corporation
    • 12.3.9. Shanghai Fosun Pharmaceuticals Ltd.
    • 12.3.10. Beijing Toplaser Technology Company Limited
    • 12.3.11. Bausch Health Companies Inc.
    • 12.3.12. Others

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦